TITLE

simian immunodeficiency virus (SIV):

AUTHOR(S)
Huber, Jeffrey T.; Gillaspy, Mary L.
PUB. DATE
October 2000
SOURCE
Encyclopedic Dictionary of AIDS-Related Terminology;2000, p201
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
A definition of the term "simian immunodeficiency virus" is presented, which refers to any of a group of viruses structurally similar to the human immunodeficiency virus found in monkeys.
ACCESSION #
23076606

 

Related Articles

  • LEAPING VIRUSES. Gravitz, Lauren // Discover;Jul2002, Vol. 23 Issue 7, p10 

    Examines the evolution of the HIV virus in France. Presence of simian immunodeficiency virus (SIV) in monkeys; Account on the evolution of HIV from chimp to SIV; Role of the vpu gene on virus transmission.

  • Researchers track ancestry of HIV to monkey meat.  // Gay & Lesbian Times;6/19/2003, Issue 808, p28 

    Reports that the ancestry of the HIV virus has been traced to two strains of virus found in monkeys in Africa. Ways by which the viruses have been passed into chimpanzees; Genetic pattern of the simian immunodeficiency virus.

  • HIV?1 neutralizing antibodies: How full is the bottle? Moore, John P.; Burton, Dennis R. // Nature Medicine;Feb1999, Vol. 5 Issue 2, p142 

    Potent neutralizing antibodies protect monkeys from SHIV challenge, but will vaccines ever be able to elicit antibody responses this powerful? (pages 204?216)

  • Genetic analyses of the promoter region of interleukin-10 gene in different species of monkeys: implications for HIV/AIDS progression. Kumarvelu, J; Shanmugasundaram, G K; Unwalla, H; Ramamoorti, N; Banerjea, A C // Genes & Immunity;Nov2001, Vol. 2 Issue 7, p404 

    Recently a number of promoter alleles of interleukin-10 (IL-10) have been described in humans that affect the progression of HIV-1. Since infection of different species of monkeys with HIV-1, HIV-2 and SIV result in a widely varying outcome of the disease, we sought to study the nature of IL-10...

  • Multiple Vaginal Exposures to Low Doses of R5 Simian-Human Immunodeficiency Virus: Strategy to Study HIV Preclinical Interventions in Nonhuman Primates. Otten, Ron A.; Adams, Debra R.; Kim, Caryn N.; Jackson, Eddie; Pullium, Jennifer K.; Lee, Kemba; Grohskopf, Lisa A.; Monsour, Michael; Butera, Sal; Folks, Thomas M. // Journal of Infectious Diseases;1/15/2005, Vol. 191 Issue 2, p164 

    A nonhuman-primate model of human immunodeficiency virus type 1 (HIV-1) infection that more closely emulates human heterosexual transmission by use of multiple exposures to low doses of virus is critical to better evaluate intervention strategies that include microbicides or vaccines. In this...

  • HIV is the hybird of two monkey viruses. Randerson, James // New Scientist;6/21/2003, Vol. 178 Issue 2400, p18 

    HIV was born out of a union more than a million years ago between two viruses that infected different species of monkey, a study of the genetic history of HIV-like viruses suggests. The union took place when chimpanzees preying on monkeys contracted the viruses, which then combined to form...

  • Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Belyakov, Igor M.; Hel, Zdenek; Kelsall, Brian; Kuznetsov, Vladimir A.; Ahlers, Jeffrey D.; Nacsa, Janos; Watkins, David I.; Allen, Todd M.; Sette, Alessandro; Altman, John; Woodward, Ruth; Markham, Phillip D.; Clements, John D.; Franchini, Genoveffa; Strober, Warren; Berzofsky, Jay A. // Nature Medicine;Dec2001, Vol. 7 Issue 12, p1320 

    Given the mucosal transmission of HIV-1, we compared whether a mucosal vaccine could induce mucosal cytotoxic T lymphocytes (CTLs) and protect rhesus macaques against mucosal infection with simian/human immunodeficiency virus (SHIV) more effectively than the same vaccine given subcutaneously....

  • HIV: A topical approach to block HIV. Buckland, Jenny // Nature Reviews Immunology;Mar2003, Vol. 3 Issue 3, p186 

    Focuses on a study by R.S. Veazey and colleagues that tested whether virus transmission can be prevented by vaginal application of b12, a monoclonal antibody specific for HIV-1 gp120. Use of simian-human immundeficiency virus-162P4 in the study; Local application of b12 in rhesus macaque...

  • Drug firms donate compounds for anti-HIV gel. Towie, Narelle // Nature;11/3/2005, Vol. 438 Issue 7064, p6 

    Reports that two drug companies have given away rights to two key compounds for anti-HIV gel. Protection of women using the gel; Number of lives that could be saved with its use; Clinical trials in Africa on monkeys.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics